// App-Quantinova.ai

: A single center experience of rituximab for anti synthetase syndrome associated interstitial lung disease (ASS-ILD)

Researchers

Presenter

  • Amila Rathnapala

Principal Investigators

  • Louise Wing

  • Rachel Benamore

  • Joel David

  • Rachel Hoyles

Medical Centers

  • National Hospital for Respiratory Diseases, Colombo, Sri Lanka

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Locations

  • Sri Lanka

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved